BDBM667089 N-(4-{7-[2-fluoro-5-(propan-2- yl)phenyl]-1H,2H,3H-pyrido[3,4- b][1,4]oxazin-1-yl}pyridin-2-yl)-3- (4-methylpiperazin-1- yl)propanamide::US20240116947, Example 34

SMILES CC(C)c1ccc(F)c(c1)-c1cc2N(CCOc2cn1)c1ccnc(NC(=O)CCN2CCN(C)CC2)c1

InChI Key InChIKey=VQFQHYIJVSQCLG-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 667089   

TargetTGF-beta receptor type-1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM667089(US20240116947, Example 34 | N-(4-{7-[2-fluoro-5-(p...)
Affinity DataIC50: 1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent